e.p.t.q. Lidocaine S300 - Synthetic-fluid tissue reconstructive material, anaesthetic
Access comprehensive regulatory information for e.p.t.q. Lidocaine S300 - Synthetic-fluid tissue reconstructive material, anaesthetic in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class III is sponsored by Xytide Biotech Pty Ltd, manufactured by Jetema Co Ltd in South Korea. The device registration started on February 22, 2024.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.
e.p.t.q. Lidocaine (S300) is intended to be used for the correction of nasolabial folds. The product is for cosmetic use only. The addition of lidocaine provides a pain-relieving effect during treatment.